CN106749133B - A method of preparing Ta Simeiqiong - Google Patents

A method of preparing Ta Simeiqiong Download PDF

Info

Publication number
CN106749133B
CN106749133B CN201510814397.2A CN201510814397A CN106749133B CN 106749133 B CN106749133 B CN 106749133B CN 201510814397 A CN201510814397 A CN 201510814397A CN 106749133 B CN106749133 B CN 106749133B
Authority
CN
China
Prior art keywords
base
dihydrobenzofuranes
reaction
cyclopropyl
simeiqiong
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510814397.2A
Other languages
Chinese (zh)
Other versions
CN106749133A (en
Inventor
李喜安
朱建荣
钟宏班
付长安
岳李荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Jingxin Pharmaceutical Co Ltd
Original Assignee
Zhejiang Jingxin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Jingxin Pharmaceutical Co Ltd filed Critical Zhejiang Jingxin Pharmaceutical Co Ltd
Priority to CN201510814397.2A priority Critical patent/CN106749133B/en
Publication of CN106749133A publication Critical patent/CN106749133A/en
Application granted granted Critical
Publication of CN106749133B publication Critical patent/CN106749133B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides the preparation method of Ta Simeiqiong a kind of; this method is with (S)-4- (ethylene oxide-2- base)-2; 3- Dihydrobenzofuranes are starting material; (1R is generated through cyanalation reaction; 2R) (2-2-; 3- Dihydrobenzofuranes-4- base) cyclopropyl formonitrile HCN, reduction generate ((1R, 2R)-2- (2,3- Dihydrobenzofuranes-4- base) cyclopropyl) methylamine and Ta Simeiqiong is made in acylation reaction again.The method of the present invention reaction step is few, easy to operate, and post-processing is easy, and product yield is high, and cost of material is low, is conducive to industrialized production, there is biggish application value.

Description

A method of preparing Ta Simeiqiong
Technical field
The present invention relates to pharmaceutical chemistry, and in particular to the preparation of drug more particularly to a kind of method for preparing Ta Simeiqiong.
Background technique
Ta Simeiqiong, trade name Hetlioz, the entitled 1R-trans of chemistry)-N- [[2- (2,3- dihydro -4- benzofurans Base) cyclopropyl] methyl] propionamide, shown in structural formula I.The medicine is developed by Maryland, USA Vanda drugmaker, and 2014 1 The approval listing of the FDA of the moon 31 is a kind of novel melatonin (melatonin) receptor stimulating agent, as blind as a bat for treating Non- 24- hours sleep arousal disorders in patient (" non-24 ")." non-24 " are that the disorders of circadian rhythms that one kind is chronic in blind person draws The sleeping time puzzlement risen, light do not enter their eyes and its biological clock and 24- hours light and shade periods cannot be made same Step, the i.e. patient are likely difficult to sleep of falling asleep or keep, some patient sleeps' modes reverse, and need to sleep and clear at night on daytime It wakes up.
Currently, the synthetic method in relation to Ta Simeiqiong is substantially to pass through preparation to have in the key of chiral cylopropyl and amino Mesosome (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl methylamine II, then intermediate II carries out amidation and obtains him Si Meiqiong.
Patent US5856529 report, with (E) -3- (2,3- Dihydrobenzofuranes -4- base) acrylic acid for starting material, with (-) -2,10- camphorsulfonic acid lactams condensation, with diazomethane carry out it is Cyclopropanated obtain chiral cylopropyl intermediate, with hydrogenation Aluminium lithium is restored, then obtains aldehyde by SWERN (polite oxidation reaction) oxidation, then oxime is condensed into hydroxylamine hydrochloride, into one Step is reduced into amine, and last and propionyl chloride reacts to obtain Ta Simeiqiong.But reactions steps of this method is longer, and must use diazonium first Alkane constructs chiral intermediate, is unfavorable for safe operation, it is difficult to industrialize, specific reaction step is as follows:
The preparation method of CN102675268 report: by (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropanecarboxylic acid Obtain (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formyl chloride through chlorination, through ammonolysis generate (1R, 2R) -2- (2, 3- Dihydrobenzofuranes -4- base) cyclopropyl formamide, most (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- are obtained through reduction afterwards Base) cyclopropyl methylamine this key intermediate.But the preparation of the starting material acid chiral cylopropyl of this method will also use diazonium first The reagents such as alkane.
Reaction step is as follows:
The method that patent US6214869 reports synthesizing cis 2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl methylamine, should Method is starting material by (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl-carbinol, protects hydroxyl with mesyl, Then the mesyl after protection and sodium azide are acted on by azide substitution, and last hydrogenated aluminium lithium restores to obtain cis- 2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl methylamine.But the technique of this method requires harshness, uses high-risk reagent N aN3, it is unfavorable for work Industry metaplasia produces.
Reaction step is as follows:
In short, the method for prior art report, which all exists, uses highly difficult, expensive reagent, complex operation, equipment Demanding defect, not can be adapted to industrial production, need to improve.
Summary of the invention
Technical problem to be solved by the present invention lies in above-mentioned shortcoming is overcome, researching and designing reaction is simple, operation letter Just, at low cost, the method for preparing Ta Simeiqiong of high income.
The present invention provides a kind of methods for preparing Ta Simeiqiong, shown in following reaction equation:
The method of the present invention includes the following steps:
(1) (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and cyanylation agent in the presence of a base, cyano Change reaction and generate (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN III:
Cyanylation agent described in the step be one of cyanogen methyl phosphorodithioate or cyanogen methyl quaternary phosphonium salt or a variety of, preferably Cyanogen methyl phosphorodithioate, most preferably cyanogen methyl acid phosphate diethylester;(S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes with The molar ratio of cyanylation agent is 1:1~5, wherein it is preferred that 1:1~3;
The alkali is selected from one of sodium hydride, sodium tert-butoxide, potassium tert-butoxide, sodium methoxide or sodium ethoxide or a variety of, preferably Sodium hydride;(S) molar ratio of -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and alkali is 1:1~5, preferably 1:1~3.
Reaction dissolvent is selected from one of toluene, paraxylene, n-hexane or hexamethylene or a variety of, preferably hexamethylene;It is molten The dosage of agent is 8~50 times, preferably 25~30 times of (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes quality.
Reaction temperature is 50~110 DEG C, preferably 70~100 DEG C;Reaction time is 4~12 hours, preferably 8~10 hours.
Post-reaction treatment: being successively then solvent by 0.5-2 times of water quenching reaction of reactant solubilization dosage every time 0.5-2 times of ethyl acetate of amount extracts 3 times, is extracted again with equivalent amount of water, merge it is organic subtract each other pressure be evaporated (40 DEG C, 0.01MPa rotation Turn evaporation), (column type silicagel column 25*500mm glass silica gel column, silica gel 200-300 mesh, eluting solvent methanol: dichloro are chromatographed through column Methane=1:10) effective component is collected, thin layer detection terminal obtains target product III.
(2) (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN with reducing agent reduction reaction generate ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine II:
Reducing agent described in the step is metal hydride, and preferred metal hydride is lithium aluminium hydride reduction;(1R,2R)-2-(2, 3- Dihydrobenzofuranes -4- base) molar ratio of cyclopropyl formonitrile HCN and reducing agent is 1:1~5, preferably 1:1~3.
Reduction reaction described in the step promotes in addition to Louis acid catalysis can also be added with metal hydride reducing agent Reaction, the lewis acid are selected from BF3、SnCl4、FeCl3、AlCl3、ZnCl2Or CuCl2, preferably BF3Or ZnCl2
Reaction dissolvent is selected from tetrahydrofuran, 2- methyltetrahydrofuran, ether, methyl tertiary butyl ether(MTBE), isopropyl ether, ethylene glycol two One of methyl ether or dioxane are a variety of, preferably tetrahydrofuran or methyltetrahydrofuran;The dosage of solvent is (1R, 2R)- 8~60 times, preferably 20~30 times of 2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN quality.
Reaction temperature is -50~100 DEG C, and preferably 20~30 DEG C, the reaction time is 0.5~12 hour, and preferably 8~10 is small When.
Post-reaction treatment: 0.5-2 times of the saturated sodium bicarbonate aqueous solution that quantity of solvent is added into reactant is quenched, and takes out Filter, for filter cake with being every time 0.1-1 times of methanol rinse 3 times of quantity of solvent, filtrate decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporation), Effective component is collected through column chromatography (column type 25*500mm, eluting solvent methanol: methylene chloride=1:10), thin layer detects terminal, Obtain object II.
(3) ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine and acylting agent, in acid binding agent In the presence of, it carries out acylation reaction and generates Ta Simeiqiong:
The reaction of the step is solvent-free or have and carry out under solvent, and the solvent is selected from methylene chloride, chloroform, 1,2- bis- One of chloroethanes, n-hexane, hexamethylene or methanol are a variety of, preferably methylene chloride;The dosage of solvent is ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) 0~50 times, preferably 5~15 times of methylamine quality.
The acylting agent is selected from one of propionyl chloride, propionic acid or propionic ester or a variety of, preferably propionyl chloride;It is described The molar ratio of ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine and acylting agent is 1:1~10, excellent Select 1:1~3.
The acid binding agent is one in triethylamine, diisopropyl ethyl amine, sodium bicarbonate, sodium carbonate, potassium carbonate or pyridine Kind is a variety of, preferably triethylamine;((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine and acid binding agent Molar ratio be 1:1~8, preferably 1:1~3.
Reaction temperature is -20~80 DEG C, preferably 0~20 DEG C;Reaction time is 0.5~12 hour, preferably 6~10 hours.
Post-reaction treatment: reactant decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporation) solvent, and column chromatographs (column type 25* 500mm, eluting solvent methanol: methylene chloride=1:10) effective component is collected, thin layer detects terminal, obtains target product I.
It is a further object of the present invention to provide compound (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl first Nitrile III, the compound following formula indicate:
It is prepared by following method:
(S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and cyanylation agent are in the presence of a base, cyanalation anti- (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN III should be generated:
The cyanylation agent is one of cyanogen methyl phosphorodithioate or cyanogen methyl quaternary phosphonium salt or a variety of, preferably cyanogen methyl Phosphate, most preferably cyanogen methyl acid phosphate diethylester;(S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes with it is cyanalation The molar ratio of reagent is 1:1~5, wherein it is preferred that 1:1~3;
The alkali is selected from one of sodium hydride, sodium tert-butoxide, potassium tert-butoxide, sodium methoxide or sodium ethoxide or a variety of, preferably Sodium hydride;(S) molar ratio of -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and alkali is 1:1~5, preferably 1:1~3.
Reaction dissolvent is selected from one of toluene, paraxylene, n-hexane or hexamethylene or a variety of, preferably hexamethylene;It is molten The dosage of agent is 8~50 times, preferably 25~30 times of (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes quality.
Reaction temperature is 50~110 DEG C, preferably 70~100 DEG C;Reaction time is 4~12 hours, preferably 8~10 hours.
Post-reaction treatment: being successively then solvent by 0.5-2 times of water quenching reaction of reactant solubilization dosage every time 0.5-2 times of ethyl acetate of amount extracts 3 times, is extracted again with equivalent amount of water, merge it is organic subtract each other pressure be evaporated (40 DEG C, 0.01MPa rotation Turn evaporation), (column type silicagel column 25*500mm glass silica gel column, silica gel 200-300 mesh, eluting solvent methanol: dichloro are chromatographed through column Methane=1:10) effective component is collected, thin layer detection terminal obtains target product III.
Compound (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) the cyclopropyl formonitrile HCN III can be prepared by reduction Ta Simeiqiong, therefore be the key intermediate of the method for the present invention.
The method of the present invention reaction step is few, easy to operate, and post-processing is easy, and product yield is high, and cost of material is low, is conducive to Industrialized production has biggish application value.
Specific embodiment
Raw materials and reagents used in following embodiment are commercially available.
(S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes be it is commercially available or
Embodiment 1 prepares Ta Simeiqiong
(1) preparation of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN III
Sodium hydride (3.9g, 2.0equiv., 98.6mmol) is added in 80mL hexamethylene, cyanogen methyl acid phosphate is slowly added dropwise Diethylester (9.6g, 1.1 equiv (equivalent), 54.2mmol), is added dropwise, is warming up to 70 DEG C, then 80mL hexamethylene is slowly added dropwise (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes (8.0g, 1.0equiv., 49.3mmol) of alkane dissolution, are added dropwise It finishes, after being warming up to 80 DEG C, reaction 8 hours, adds water 50ml quenching reaction, then successively through ethyl acetate 100ml*3, water 100ml extraction, merges organic pressure of subtracting each other and is evaporated (40 DEG C, 0.01MPa rotary evaporation), chromatographs (column type silicagel column 25* through column 500mm glass silica gel column, silica gel 200-300 mesh, eluting solvent methanol: methylene chloride=1:10) collect effective component, thin layer inspection It surveys terminal and obtains III grease 7.8g of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN, yield 86%.
It is object III through detection confirmation.
1HNMR(CDCl3) δ 7.08 (t, J=8.0Hz, 1H), 6.73 (d, J=8.0Hz, 1H), 6.40 (d, J=8.0Hz, 1H), 4.66 (t, J=8.0Hz, 2H), 3.33-3.29 (m, 2H), 2.58-2.53 (m, 1H), 1.66-1.62 (m, 1H), 1.59- 1.54(m,1H),1.51-1.50(m,1H).13CNMR(CDCl3)δ160.13,134.20,128.61,126.99,121.06, 116.09,108.53,71.16,28.52,22.86,14.46,5.58.MS (ESI): m/z=285.2,280.0 (M+Na+)
(2) ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine II preparation by (1R, 2R) -2- (2, 3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN (3g, 1.0 equivalents, 16.2mmol) is dissolved in 120mL2- methyltetrahydrofuran, adds After ice bath is cooling, (0-5 DEG C) is added portionwise lithium aluminium hydride reduction (0.92g, 1.5equiv., 24.3mmol) and adds saturated carbon after 3 hours Sour hydrogen sodium water solution 100ml is quenched, and filters, filter cake with methanol rinse 3 times (each 10ml), filtrate decompression be spin-dried for (40 DEG C, 0.01MPa rotary evaporation), through column chromatography (column type 25*500mm, eluting solvent methanol: methylene chloride=1:10) collect effectively at Point, thin layer detection terminal obtains 2.95g object, yield 96%;
(3) N- (((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methyl) propionamide (Ta Simeiqiong) I Preparation
((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine (2.48g, 1.0equiv., 13.1mmol) be dissolved in 30mL methylene chloride, the cooling 0-5OC of bath on the rocks, with syringe be added propionyl chloride (1.33g/1.3mL, 1.1equiv., 14.4mmol), have white solid generation at once, then be added dropwise triethylamine (1.32g/1.8mL, 1.0equiv., 13.1mmol), system becomes clarification immediately, after half an hour, removes ice bath, overnight, reactant decompression is revolved for (20-25 DEG C) of room temperature reaction Dry (40 DEG C, 0.01MPa rotary evaporation) solvent, column chromatograph (column type 25*500mm, eluting solvent methanol: methylene chloride=1:10) Effective component is collected, thin layer detects terminal get Ta Simeiqiong product 2.8g, yield 88%.
Obtaining product through detection confirmation is Ta Simeiqiong.
MS[M+H]:246.1
Embodiment 2 prepares Ta Simeiqiong
(1) preparation of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN III
Potassium tert-butoxide (16.6g, 2.0equiv., 147.9mmol) is added in 200mL toluene, cyanogen methyl phosphorus is slowly added dropwise Diethyl phthalate (26.2g, 3 equivalents, 147.9mmol), is added dropwise, is warming up to 100 DEG C, then the dissolution of 100mL toluene is slowly added dropwise (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes (8.0g, 1.0 equivalents, 49.3mmol), be added dropwise, maintain After 100 DEG C are reacted 10 hours, add 50ml water quenching reaction, then through extracting ethyl acetate 100*3ml and water 100ml, organic phase Evaporated under reduced pressure (40 DEG C, 0.01MPa rotary evaporation), through column chromatography (column type 25*500mm, eluting solvent methanol: methylene chloride= Effective component 1:10) is collected, thin layer detection terminal obtains grease 9.0g, yield 88%.
(2) ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine II preparation by (1R, 2R) -2- (2, 3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN (3g, 1.0 equivalent 6.2mmol) is dissolved in 100mL isopropanol, 0-5 DEG C of bath on the rocks After cooling, lithium aluminium hydride reduction (1.85g, 3 equivalents, 48.6mmol) are added portionwise, after 3 hours, saturated sodium bicarbonate are added to be quenched, takes out Filter, for filter cake with 10ml isopropyl alcohol 3 times, filtrate decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporation), chromatographs (column type through column 25*500mm, eluting solvent methanol: methylene chloride=1:10 collect effective component, and thin layer detects terminal, obtains III 2.98g, yield 97%;
(3) N- (((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methyl) propionamide (Ta Simeiqiong) I Preparation
((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine (2.48g, 1.0equiv., 13.1mmol) be dissolved in 50mL n-hexane, (0-5 DEG C) cooling of bath on the rocks, with syringe be added propionyl chloride (1.33g/1.3mL, 1.1 equivalents, 14.4mmol), there is white solid generation at once, potassium carbonate (1.8g, 1.0 equivalents, 13.1mmol) then is added, body System becomes clarification immediately, after half an hour, removes ice bath, overnight, (40 DEG C, 0.01MPa rotation is steamed for decompression for (20-25 DEG C) of room temperature reaction Hair) it is spin-dried for solvent, column chromatographs (column type 25*500mm, eluting solvent methanol: methylene chloride=1:10) and collects effective component, thin layer Terminal is detected, product Ta Simeiqiong 2.9g, yield 90% are obtained.
Obtaining product through detection confirmation is Ta Simeiqiong.
Embodiment 3 prepares (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN III
Sodium hydride (3.9g, 2.0 equivalents, 98.6mmol) are added in 100mL n-hexane, cyanogen methyl acid phosphate two is slowly added dropwise Ethyl ester (8.72g, 1 equivalent, 49.3mmol), is added dropwise, temperature rising reflux, then (S)-of 100mL n-hexane dissolution is slowly added dropwise 4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes (8.0g, 1.0 equivalents, 49.3mmol), are added dropwise, back flow reaction 4 After hour, adds 50ml water quenching reaction, then successively extracted (ethyl acetate 100*3ml;Water 100ml), organic phase decompression is steamed Dry (40 DEG C, 0.01MPa rotary evaporation) are received through column chromatography (column type 25*500mm, eluting solvent methanol: methylene chloride=1:10) Collect effective component, thin layer detects terminal, obtains III 7.7g of grease, yield 85%.
Obtaining product through detection confirmation is III.
Embodiment 4 prepares ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine II
By (1R, 2R) -2- made from embodiment 3 (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN (3g, 1.0 equivalents, It 16.2mmol) is dissolved in 120mL tetrahydrofuran, is added portionwise at room temperature lithium aluminium hydride reduction (0.92g, 1.5 equivalents, 24.3mmol), 3 After hour, saturated sodium bicarbonate is added to be quenched, filtered, filter cake is rinsed 3 times with 10ml tetrahydrofuran respectively, and filtrate decompression is spin-dried for (at 40 DEG C, 0.01MPa rotary evaporation) are received through column chromatography (column type 25*500mm, eluting solvent methanol: methylene chloride=1:10) Collect effective component, thin layer detects terminal, obtains II 2.85g, yield 93%.
Obtaining product through detection confirmation is II.
Embodiment 5 prepares ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine II
By (1R, 2R) -2- made from embodiment 3 (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN (3g, 1.0 equivalents, 16.2mmol) be dissolved in 120mL tetrahydrofuran, be added portionwise at room temperature lithium aluminium hydride reduction (0.92g, 1.5 equivalents, 24.3mmol) and Zinc chloride (0.22g, 0.1 equivalent, 1.62mmol), after 2 hours, adds saturated sodium bicarbonate to be quenched, and filters, filter cake tetrahydrofuran Rinsing 3 times, filtrate decompression is spin-dried for (at 40 DEG C, 0.01MPa rotary evaporation), chromatographs (column type 25*500mm, eluting solvent first through column Alcohol: methylene chloride=1:10) effective component is collected, thin layer detects terminal, obtains II 2.91g, yield 95%;
Obtaining product through detection confirmation is II.
Embodiment 6
N- (((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methyl) propionamide (Ta Simeiqiong) I system It is standby
((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine made from embodiment 5 (2.48g, 1.0equiv., 13.1mmol) be dissolved in 1, the 2- dichloroethanes of 30mL, with syringe be added propionic acid (2.9g, 3equiv., 39.3mmol), back flow reaction 10 hours, decompression are spin-dried for solvent (40 DEG C, 0.01MPa rotary evaporation), and column chromatographs (column type 25* 500mm, eluting solvent methanol: methylene chloride=1:10) effective component is collected, thin layer detects terminal, obtains product Ta Simeiqiong 2.2g, yield 71%.
It is Ta Simeiqiong through detection confirmation.

Claims (11)

1. a kind of method for preparing Ta Simeiqiong, it is characterised in that this method reaction equation:
The following steps are included:
(1) in the presence of a base, reaction generates for (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and cyanylation agent (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN III:
(2) (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN is restored with reducing agent and generates ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine II:
(3) ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine and acylting agent exist in acid binding agent Lower reaction generates Ta Simeiqiong I:
2. the method according to claim 1 for preparing Ta Simeiqiong, which is characterized in that step (1) the cyanalation reaction The reagent used is one of cyanogen methyl phosphorodithioate or cyanogen methyl quaternary phosphonium salt or a variety of;(S) -4- (ethylene oxide -2- base) -2, The molar ratio of 3- Dihydrobenzofuranes and cyanylation agent is 1:1~5;The alkali is selected from sodium hydride, sodium tert-butoxide, the tert-butyl alcohol One of potassium, sodium methoxide or sodium ethoxide are a variety of;(S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and alkali Molar ratio is 1:1~5;
Reaction dissolvent is selected from one of toluene, paraxylene, n-hexane or hexamethylene or a variety of;The dosage of solvent is (S) -4- 8~50 times of (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes quality;
Reaction temperature is 50~110 DEG C;Reaction time is 4~12 hours.
3. the method according to claim 2 for preparing Ta Simeiqiong, which is characterized in that cyanalation anti-described in step (1) The reagent that should be used is cyanogen methyl acid phosphate diethylester;(S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes with it is cyanalation The molar ratio of reagent is 1:1~3;
The alkali is sodium hydride;(S) molar ratio of -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes and alkali be 1:1~ 3;
Reaction dissolvent is hexamethylene;The dosage of solvent is (S) -4- (ethylene oxide -2- base) -2,3- Dihydrobenzofuranes quality 25~30 times;
Reaction temperature is 70~100 DEG C;Reaction time is 8~10 hours.
4. the method according to claim 1 for preparing Ta Simeiqiong, which is characterized in that step (2) reducing agent is gold Belong to hydride;The molar ratio of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN and reducing agent is 1:1~5;
Reaction dissolvent is selected from tetrahydrofuran, 2- methyltetrahydrofuran, ether, methyl tertiary butyl ether(MTBE), isopropyl ether, glycol dimethyl ether Or one of dioxane or a variety of;The dosage of solvent is (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl first 8~60 times of nitrile quality;
Reaction temperature is -50~100 DEG C;Reaction time is 0.5~12 hour.
5. the method according to claim 4 for preparing Ta Simeiqiong, which is characterized in that step (2) described metal hydride For lithium aluminium hydride reduction.
6. the method according to claim 4 for preparing Ta Simeiqiong, which is characterized in that step (2) reducing agent is gold Category hydride is lithium aluminium hydride reduction;The molar ratio of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN and reducing agent For 1:1~3;
Reaction dissolvent is selected from tetrahydrofuran or 2- methyltetrahydrofuran;The dosage of solvent is (1R, 2R) -2- (2,3- dihydrobenzo Furans -4- base) 20~30 times of cyclopropyl formonitrile HCN quality.
7. the method according to claim 3 or 4 for preparing Ta Simeiqiong, which is characterized in that the reduction reaction of step (2) is removed Metal hydride reducing agent is used, Louis acid catalysis is additionally added and promotes reaction, the lewis acid is selected from BF3、SnCl4、 FeCl3、AlCl3、ZnCl2Or CuCl2
8. the method according to claim 7 for preparing Ta Simeiqiong, which is characterized in that the reduction reaction of step (2) in addition to With metal hydride reducing agent, it is additionally added Louis acid catalysis and promotes reaction, the lewis acid is selected from BF3Or ZnCl2
9. the method according to claim 1 for preparing Ta Simeiqiong, which is characterized in that the acylation reaction of step (3) exists Solvent-free or have and carry out under solvent, the solvent is selected from methylene chloride, chloroform, 1,2- dichloroethanes, n-hexane, hexamethylene or first One of alcohol is a variety of;The dosage of solvent is ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine matter 0~50 times of amount;
The acylting agent is selected from one of propionyl chloride, propionic acid or propionic ester or a variety of;((1R, the 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) molar ratio of methylamine and acylting agent is 1:1~10;
The acid binding agent is selected from one of triethylamine, diisopropyl ethyl amine, sodium bicarbonate, sodium carbonate, potassium carbonate or pyridine Or it is a variety of;The molar ratio of ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine and acid binding agent is 1:1 ~8;
Reaction temperature is -20~80 DEG C;Reaction time is 0.5~12 hour.
10. the method according to claim 9 for preparing Ta Simeiqiong, which is characterized in that
Solvent described in acylation reaction described in step (3) is methylene chloride;The dosage of solvent is ((1R, 2R) -2- (2,3- bis- Hydrogen benzofuran -4- base) cyclopropyl) 5~15 times of methylamine quality;
The acylting agent is propionyl chloride;((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine Molar ratio with acylting agent is 1:1~3;
The acid binding agent is triethylamine;((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl) methylamine with tie up The molar ratio of sour agent is 1:1~3;
Reaction temperature is 0~20 DEG C;Reaction time is 6~10 hours.
Compound 11. (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- base) cyclopropyl formonitrile HCN, which is characterized in that the compound Following formula indicates:
CN201510814397.2A 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong Active CN106749133B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510814397.2A CN106749133B (en) 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510814397.2A CN106749133B (en) 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong

Publications (2)

Publication Number Publication Date
CN106749133A CN106749133A (en) 2017-05-31
CN106749133B true CN106749133B (en) 2019-01-29

Family

ID=58885224

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510814397.2A Active CN106749133B (en) 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong

Country Status (1)

Country Link
CN (1) CN106749133B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105949153B (en) * 2016-05-10 2018-03-02 浙江工业大学 A kind of Ta Simeiqiong synthetic method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CN102675268A (en) * 2012-05-18 2012-09-19 济南志合医药科技有限公司 Method for preparing (1R,2R)-2-(2,3-dihydrobenzofuran-4-yl) cyclopropanemethylamine
CN103664697A (en) * 2012-09-07 2014-03-26 博瑞生物医药技术(苏州)有限公司 Chemical method used for preparing aromatic cyclopropanecarbonitrile and cyclopropylamine
CN104327022A (en) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 Preparation method of tasimelteon

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CN102675268A (en) * 2012-05-18 2012-09-19 济南志合医药科技有限公司 Method for preparing (1R,2R)-2-(2,3-dihydrobenzofuran-4-yl) cyclopropanemethylamine
CN103664697A (en) * 2012-09-07 2014-03-26 博瑞生物医药技术(苏州)有限公司 Chemical method used for preparing aromatic cyclopropanecarbonitrile and cyclopropylamine
CN104327022A (en) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 Preparation method of tasimelteon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Development of Jacobsen Asymmetric Epoxidation and Sharpless Asymmetric Dihydroxylation Methods for the Large-Scale Preparation of a Chiral Dihydrobenzofuran Epoxide;J.Siva Prasad et al.,;《Organic Process Research & Development》;20030910;第7卷;第821-827页

Also Published As

Publication number Publication date
CN106749133A (en) 2017-05-31

Similar Documents

Publication Publication Date Title
CN105061224B (en) Synthetic method of L-2-aminobutanol
CN106365986B (en) Compound and preparation method thereof and the purposes in synthesis Bu Waxitan
CN101146810A (en) Method for making 1-substituted 1H-imidazo[4,5-c]quinolin-4-amine compounds and intermediates therefor
CN103160562A (en) Method of synthetizing levo-praziquantel
Shinu et al. An efficient green MCR protocol for the stereoselective synthesis of β-acetamido ketones catalyzed by Selectfluor™
CN106749133B (en) A method of preparing Ta Simeiqiong
CN105949153B (en) A kind of Ta Simeiqiong synthetic method
CN103772278A (en) Important tetrahydroisoquinoline derivative midbody and synthesis method thereof
CN103896858B (en) The preparation technology of cytosine
CN107501196B (en) Intermediates for the preparation of diazepam-D5 and diazepam-D8 and processes for their preparation
CN103787975A (en) Huperzine A D-dibenzoyltartartrate and preparation method and application thereof
CN106946880B (en) A method of preparing Rui Boxini intermediate
CN103992302A (en) Synthesis process of 2-thiopheneacetic acid
CN116621810A (en) Process for preparing 2-methyl nicotine
CN105237406A (en) Synthesis method of (R)-(-)-1-methyl-3-amphetamine
CN105968103B (en) The synthetic method of anti-tumor drug Afatinib
CN105884746B (en) The synthetic method of fluorine imatinib
CN104649966A (en) Method for synthesizing organic intermediate 5-cyano-3-methylpyridine formic acid
CN104829571B (en) Escitalopram oxalate related substances and preparation method thereof
KR20160027536A (en) Process for preparing an intermediate useful for the synthesis of silodosin
CN106008363B (en) The preparation method of 2- methyl -4- amino-5-cyanopyrimidines
TWI361191B (en) Method of preparing (6r)-3-hexyl-4-hydroxy-6-undecyl-5,6-dihydropyran-2-one, and intermediate used in the method
CN113024479A (en) Preparation method of clomazone
CN103539794A (en) Salifying method of lurasidone hydrochloride
CN103288671A (en) Synthetic method of (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant